Company / Capital Expenditures
QuidelOrtho Capital Expenditures History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$188.2M
FY2025
5-year range
$64.9M / $209.3M
FY2021-FY2025
Trend
-3.5%
vs FY2024
Sector context
#43 of 145
Health Care
What the data says
At $188M, QuidelOrtho's capital expenditures ranks #43 of 145 in the Health Care sector. Declined from $209M to $188M over the past 2 years.
Based on SEC 10-K filings.
$188M in FY2025 with a 5-year CAGR of +23.7%.
Declined from $209M to $188M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +10.1%
- 5-Year CAGR
- +23.7%
- 10-Year CAGR
- -
Sector benchmark
#43 of 145 in Health CareTop 30% of 145This company $188.2M Sector average $268.6M
▼
-29.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.7%, indicating consistent growth.
- In FY2025, capital expenditures decreased 3.5% year-over-year.
- Ranks #43 out of 145 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $188.2M | -3.5% |
| FY2024 | $195.1M | -6.8% |
| FY2023 | $209.3M | +48.5% |
| FY2022 | $140.9M | +117.1% |
| FY2020 | $64.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026